October 26, 2025
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: Federal Circuit Vacates $300 Million Verdict Against Apple, Orders Third Trial in LTE Patent Dispute
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Biotechnology > Federal Circuit Vacates $300 Million Verdict Against Apple, Orders Third Trial in LTE Patent Dispute
Biotechnology

Federal Circuit Vacates $300 Million Verdict Against Apple, Orders Third Trial in LTE Patent Dispute

By Newsroom
Last updated: July 11, 2025
1 Min Read
Share


In a pivotal ruling for patent damages and standard-essential patent (SEP) litigation, the Federal Circuit vacated a $300 million award against Apple in a long-standing dispute with Optis Cellular Technology, LLC. See Optis Cellular Tech., LLC v. Apple Inc. (“Op.”). The Federal Circuit sided with Apple on multiple fronts—vacating the damages and infringement findings, reversing § 101 findings on the claims of one of Optis’s patents, and reversing a finding that another patent did not invoke 35 USC § 112 ¶6 (The patent at issue was issued pre-AIA so §112(f) is referred to as 112 ¶ 6 as in the original statute language). The…



Source link

Share This Article
Facebook Email Copy Link Print

HOT NEWS

New York’s Climate Change Superfund Act

Environmental Science
April 5, 2025

Executive Brief: Compliant Targeting Ailment-Specific…

Compliant Targeting Ailment-Specific Audiences The Challenge: Healthcare and pharmaceutical companies face a critical challenge: reaching consumers…

October 24, 2025

As Part of the “AfriSummit 2024” Activities A High-Level Meeting between Uganda and Egypt to Strengthen Pharmaceutical Cooperation and Expand the African Market

A high-level meeting between Uganda and Egypt to strengthen pharmaceutical cooperation CAIRO, Egypt (AfricaNewswire.Net) —…

April 5, 2025

ضمن فعاليات “قمة إفريقيا للشؤون التنظيمية 2024” اجتماع رفيع بين أوغندا ومصر لتعزيز التعاون الدوائي وتوسيع السوق الإفريقية

اجتماع رفيع المستوى بين أوغندا ومصر لتعزيز التعاون الصيدلاني القاهرة، مصر، نوفمبر 2024 (AfricaNewswire.Net)  في…

April 5, 2025

YOU MAY ALSO LIKE

The Chisum Patent Academy Makes an Appearance in Cincinnati |

When I was in law school, we had but one treatise to use, the weighty “Choate on Patents” (1973). A…

Biotechnology
April 5, 2025

Is the Patent Eligibility Act a Panacea for Claims to Diagnostics? |

On January 23, the Subcommittee on Intellectual Property held a hearing in which the members of the committee heard testimony…

Biotechnology
April 5, 2025

Value and Risk of Overlapping Intellectual Property Protections

A well-orchestrated intellectual property strategy requires carefully and thoughtfully leveraging copyright, trademark, and patent laws, as highlighted by a recent…

Biotechnology
May 16, 2025

Stay Aware: Remote Employees Impact Venue Options In Patent Litigation

For many patent cases, the United States District Court hearing your patent dispute can have a big impact on case…

Biotechnology
October 19, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

Executive Brief: Compliant Targeting Ailment-Specific…
October 24, 2025
Webinar: Building the leadership teams that launch in Europe
October 24, 2025
Israel vertuscht kritische Treffer + China mit krasser Kriegs-Drohung + EU-Sanktionen gegen Israel!
October 24, 2025
How to accelerate time-to-insight with better RWD
October 24, 2025

Life Science Magazines

Executive Brief: Compliant Targeting Ailment-Specific…
October 24, 2025
Webinar: Building the leadership teams that launch in Europe
October 24, 2025
How to accelerate time-to-insight with better RWD
October 24, 2025
How multimodal data is transforming drug discovery
October 23, 2025

LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?